The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Thermo Fisher Scientific Inc

NYSE: TMO
Last

(U.S.) $144.55

Today's change-0.32 -0.22%
Updated May 4 4:02 PM EDT. Delayed by at least 15 minutes.
 

Thermo Fisher Scientific Inc

NYSE: TMO
Last

(U.S.) $144.55

Today's change-0.32 -0.22%
Updated May 4 4:02 PM EDT. Delayed by at least 15 minutes.

Thermo Fisher Scientific Inc down (U.S.)$0.32

Thermo Fisher Scientific Inc closed lower Wednesday, dropping (U.S.)$0.32 or 0.22% to (U.S.)$144.55. Shares have lost 1.76% over the last five days, but are unchanged over the last year to date. This security has outperformed the S&P 500 by 16.12% during the last year.

Key company metrics

  • Open(U.S.) $143.23
  • Previous close(U.S.) $144.87
  • High(U.S.) $145.03
  • Low(U.S.) $142.98
  • Bid / Ask-- / --
  • YTD % change+1.90%
  • Volume982,477
  • Average volume (10-day)1,556,891
  • Average volume (1-month)1,292,810
  • Average volume (3-month)1,863,466
  • 52-week range(U.S.) $117.10 to (U.S.) $147.94
  • Beta1.03
  • Trailing P/E29.04×
  • P/E 1 year forward17.86×
  • Forward PEG1.73×
  • Indicated annual dividend(U.S.) $0.60
  • Dividend yield0.42%
  • Trailing EPS(U.S.) $4.98
Updated May 4 4:02 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+11.52%

Based on its net profit margin of 11.52%, Thermo Fisher Scientific Inc is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.55%Sector:HealthcareIndustry:Advanced Medical Equipment
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2016Q4/2015Q3/2015Q2/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedApr 02, 201604/02/2016Dec 31, 201512/31/2015Sep 26, 201509/26/2015Jun 27, 201506/27/2015
Revenue4,2954,6534,1234,271
Total other revenue--------
Total revenue4,2954,6534,1234,271
Gross profit2,0592,1081,8831,942
Total cost of revenue2,2362,5442,2402,329
Total operating expense3,7773,9623,5603,675
Selling / general / administrative9921,1801,1091,148
Research & development177180172175
Depreciation / amortization322------
Interest expense (income), net operating--------
Unusual expense (income)51584024
Other operating expenses, total--------
Operating income518690563596
Interest income (expense), net non-operating-106-103-101-103
Gain (loss) on sale of assets--------
Other--------
Income before tax423583468504
Income after tax402606477512
Income tax, total21-24-9-8
Net income402603476512
Total adjustments to net income--------
Net income before extra. items402606477512
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items402606477512
Inc. avail. to common incl. extra. items402603476512
Diluted net income403603476512
Dilution adjustment0------
Diluted weighted average shares399403402402
Diluted EPS excluding extraordinary itemsvalue per share1.011.511.191.27
Dividends per sharevalue per share--0.150.150.15
Diluted normalized EPSvalue per share1.131.621.251.31